MENU
+Compare
PBH
Stock ticker: NYSE
AS OF
Nov 13 closing price
Price
$59.99
Change
-$0.52 (-0.86%)
Capitalization
2.88B

PBH Prestige Consumer Healthcare Forecast, Technical & Fundamental Analysis

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers... Show more

PBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PBH with price predictions
Nov 12, 2025

PBH sees its Stochastic Oscillator climbs out of oversold territory

On November 10, 2025, the Stochastic Oscillator for PBH moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PBH just turned positive on November 11, 2025. Looking at past instances where PBH's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PBH advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

PBH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PBH as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PBH entered a downward trend on November 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PBH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.581) is normal, around the industry mean (18.827). P/E Ratio (14.849) is within average values for comparable stocks, (71.764). Projected Growth (PEG Ratio) (2.122) is also within normal values, averaging (1.856). PBH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.690) is also within normal values, averaging (39.291).

View a ticker or compare two or three
PBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PBH is expected to report earnings to rise 15.89% to $1.24 per share on February 05

Prestige Consumer Healthcare PBH Stock Earnings Reports
Q4'25
Est.
$1.24
Q3'25
Beat
by $0.10
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.30
Q4'24
Beat
by $0.06
The last earnings report on November 06 showed earnings per share of $1.07, beating the estimate of 97 cents. With 433.50K shares outstanding, the current market capitalization sits at 2.88B.
A.I. Advisor
published General Information

General Information

a company which markets over-the-counter drugs, household cleaning and personal care products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
660 White Plains Road
Phone
+1 914 524-6800
Employees
560
Web
https://www.prestigebrands.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MOSSX10.200.06
+0.59%
MassMutual Overseas R5
STREX21.810.12
+0.55%
Sterling Capital Equity Income R6
TWDAX20.120.10
+0.50%
Templeton World Adv
EIPFX19.420.01
+0.05%
EIP Growth and Income Investor
JGTTX44.21-0.10
-0.23%
JPMorgan Growth Advantage R3

PBH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.12%
PAHC - PBH
40%
Loosely correlated
-0.02%
IRWD - PBH
32%
Poorly correlated
+7.61%
AMRX - PBH
31%
Poorly correlated
-0.42%
ELAN - PBH
29%
Poorly correlated
-3.54%
PRGO - PBH
29%
Poorly correlated
-0.98%
More

Groups containing PBH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.12%
Pharmaceuticals: Generic
industry (214 stocks)
23%
Poorly correlated
-1.00%